I.V. Selonabant in Healthy Adult Subjects
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy Volunteers
In brief
This is a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Selonabant in Healthy Adult Subjects Aged 18 to 30 Years
Key facts
- Study ID
- NCT07211607
- Run by
- Anebulo Pharmaceuticals
- People needed
- 40
- Starts
- 2025-09-22
- Expected to finish
- 2026-05-06
- Last updated by the study team
- 2026-05-08
Who can join
Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.
Where it is running
- PPD Austin Clinical Research Unit — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.